Sasha gentling joins biosig technologies, inc. as director of business development and investments

Biosig technologies, inc. announced that the company further expanded its investor relations team by appointing ms. sasha gentling, cfa as director of business development and investments. minnesota based ms. gentling becomes the first employee of biosig’s rochester office. prior to joining the company, ms. gentling served as investment officer at mayo clinic, a role, in which she managed key components of mayo clinic’s investment portfolio, overseeing external manager relationships in absolute return core credit hedge fund strategies, fixed income, and real estate private equity, as well as conducting comprehensive due diligence on potential new investments in both public and private markets. prior to that role ms. gentling managed investor communications and marketing activities at connecticut based discerene group, during which time aum increased by over $700 million.
BSGM Ratings Summary
BSGM Quant Ranking